Viewing Study NCT01088620


Ignite Creation Date: 2025-12-25 @ 4:13 AM
Ignite Modification Date: 2025-12-26 @ 3:11 AM
Study NCT ID: NCT01088620
Status: SUSPENDED
Last Update Posted: 2013-03-14
First Post: 2010-03-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer
Sponsor: WiSP Wissenschaftlicher Service Pharma GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module